NCT06573190View on ClinicalTrials.gov

Liver Status and Presence of MASLD/MASH in Patients With Chronic Hepatitis B

CompletedOBSERVATIONAL

Enrollment

70

Participants

Timeline

Start Date

January 2, 2023

Primary Completion Date

April 25, 2023

Study Completion Date

May 15, 2024

Conditions

Chronic Hepatitis BHepatic Steatosis

Interventions

DIAGNOSTIC_TEST

Transient elastography

Liver Stiffness Measurement, Controlled Attenuation Parameter

DRUG

Tenofovir Disoproxil Fumarate

Guided Therapy

Trial Locations (1)

TR-06540

Guven Hospital, Ankara

Sponsors

Collaborators (1)

Nobel Pharmaceuticals

All Listed Sponsors

collaborator

Nobel Pharmaceuticals

INDUSTRY

lead

Yaşar Bayındır, MD

OTHER